1
Strickland James A, Atchley Frank S, Rossman James M, Desmarais Armand J, Williams Scott A, Miller Tod J, Johnson Cherne W: Tobacco compositions. Us Smokeless Tobacco Company, Strickland James A, Atchley Frank S, Rossman James M, Desmarais Armand J, Williams Scott A, Miller Tod J, Johnson Cherne W, DECAMP James D, May 26, 2005: WO/2005/046363 (62 worldwide citation)

The invention features tobacco compositions and methods of their use and manufacture. Compositions of the invention may be based on a variety of technologies. Technologies include films, tabs, shaped parts, gels, consumable units, insoluble matrices, and hollow shapes. In addition to tobacco, compos ...


2
Strickland James A, Atchley Frank S, Rossman James M, Desmarais Armand J, Williams Scott A, Miller Tod J, Johnson Cherne W: Tobacco compositions. Us Smokeless Tobacco Company, Strickland James A, Atchley Frank S, Rossman James M, Desmarais Armand J, Williams Scott A, Miller Tod J, Johnson Cherne W, DECAMP James D, November 30, 2006: WO/2006/127772 (41 worldwide citation)

The invention features tobacco compositions and methods of their use and manufacture. Compositions of the invention may be based on a variety of technologies. Technologies include films, tabs, shaped parts, gels, consumable units, insoluble matrices, and hollow shapes. In addition to tobacco, compos ...


3
Xu Dongmei, Nielsen Mark T: Nicotiana nucleic acid molecules and uses thereof. Us Smokeless Tobacco Company, Xu Dongmei, Nielsen Mark T, DECAMP James D Ph, November 24, 2005: WO/2005/111217 (36 worldwide citation)

The present invention features Nicotiana nucleic acid sequences such as sequences encoding constitutive, or ethylene or senescence induced polypeptides, in particular cytochrome p450 enzymes, in Nicotiana plants and methods for using these nucleic acid sequences and plants to alter desirable traits, ...


4

5
Xu Dongmei: Tobacco nicotine demethylase genomic clone and uses thereof. Us Smokeless Tobacco Company, Xu Dongmei, DECAMP James D, December 8, 2005: WO/2005/116199 (28 worldwide citation)

The present invention features tobacco nicotine demethylase nucleic acid and amino acid sequences, tobacco plants and plant components containing such sequences, including tobacco plants and plant components having reduced expression or altered enzymatic activity of nicotine demethylase, methods of ...


6

7
Lawrence Robert H Jr: Nicotiana compositions. Us Smokeless Tobacco Company, Lawrence Robert H Jr, DECAMP James D, March 2, 2006: WO/2006/022784 (25 worldwide citation)

The invention features a blended smokeless tobacco composition that includes two of the following tobaccos: Nicotiana acaulis, Nicotiana acuminata, Nicotiana acuminata var. multiflora, Nicotiana africana, Nicotiana alata, Nicotiana amplexicaulis, Nicotiana arentsii, Nicotiana attenuata, Nicotiana be ...


8
Manohar John, Kudva Indira T, Calderwood Stephen B: escherichia coli o157:h7 proteins and uses thereof. The General Hospital Corporation, Manohar John, Kudva Indira T, Calderwood Stephen B, DECAMP James D, October 26, 2006: WO/2006/113907 (6 worldwide citation)

Immunogenic Escherichia coli O157:H7 (0157) proteins expressed during infection of a mammal, are described. In particular, 0157 proteins expressed specifically in vivo during human and cattle infection were identified. These proteins, mapped to the backbone, O-islands (OIs) and pO157. Because these- ...


9
CABANA ALAIN: Microspheres for sustained release of octreotide acetate. AMBRILIA BIOPHARMA, Decamp James D, September 15, 2011: WO/2011/112576 (6 worldwide citation)

The present invention provides Octreotide acetate-loaded microspheres comprised of a linear PLGA co-polymer having a ratio of Octreotide acetate to PLGA co polymer of between 0.03 and 0.07 (g/g). Microspheres of the invention, compositions and formulations thereof are free of chlorinated solvent and ...


10
Szostak Jack W, Litovchick Alexander: (hcv) Infection. The General Hospital Corporation, Szostak Jack W, Litovchick Alexander, DECAMP James D, May 28, 2009: WO/2009/067191 (5 worldwide citation)

The invention features methods and compositions for treating HCV infection. Compositions include peptides (e.g., modified peptides) that specifically bind to HCV IRES.



Click the thumbnails below to visualize the patent trend.